ViRAZE has a patented technology to discover first-in-class small molecules to treat viral diseases, focused on skin diseases with unsatisfactory treatments. We are developing the first FDA approved drug to treat the very infectious and painful viral skin disease Molluscum contagiosum (MC), and have discovered a novel compound with positive activity in human skin. We will develop the product to a suitable inflection for exit to Big Pharma.